Despite its many benefits, CBD remains highly stigmatised in France, while our European neighbours have made room for this highly promising market.
CBD and cannabis: a persistent misconception
One of the biggest obstacles to CBD’s success is its cousin, cannabis. Visually, there is no difference between the cannabis plant and the hemp plant from which CBD is derived.
The difference lies in their composition. Cannabis plants contain between 15 and 25% THC, while hemp contains less than 0.3%. This is also why it is called light cannabis.
THC is a molecule found in both hemp and cannabis, and it is what led to the cannabis plant being classified as a narcotic. THC causes psychotropic effects and, with regular use, can lead to dependence.
CBD is therefore often confused with cannabis. However, the WHO has come out in favour of CBD. Its experts consider that CBD poses no risk to health and should therefore not be classified as a narcotic.
The Court of Justice of the European Union also reaffirmed this position in the Kanavape case: French entrepreneurs were taken to court for offering CBD e-cigarettes for sale. The European Court ruled in their favour.
France is dragging its feet on CBD
On 31 December last year, the Government decided, with little publicity, to issue a decree banning the sale of CBD flowers and leaves in France. At the same time, and quite logically, it raised the permitted THC level in other hemp-derived products from 0.2% to 0.3%.
This decision clearly reflects the Government’s approach to CBD and, inevitably, to the legalisation of cannabis.
Although the decree has now been temporarily suspended, it has nevertheless raised many questions about whether CBD should be classified as a narcotic.
CBD professionals will therefore have to demonstrate its benefits if they are to see its status reassessed at last.
This also highlights another absurdity: there are still no studies in France on the therapeutic properties of cannabidiol, even though the number of such studies abroad is continually growing. CBD has been extensively studied, and hundreds of scientific studies now demonstrate its various effects on our wellbeing.
What are the benefits of CBD?
Extensive scientific research has been conducted into the effects of CBD on the body.
The results of these studies have shown that cannabidiol is a cannabinoid, meaning it can interact with our endocannabinoid system by modifying the messages it transmits. These receptors are distributed throughout the body, suggesting that CBD could therefore have a wide range of applications.
Medical research has already shown that cannabidiol:
Eases stress and anxiety
Relieves pain (rheumatism, migraines, period pain…)
Reduces skin problems by purifying, soothing and regulating sebum production
Helps athletes recover better after exercise
Acts as an anti-inflammatory
Is an effective antispasmodic and aids digestion
Improves sleep quality and helps you fall asleep faster (it can be very beneficial for people with sleep disorders)
Helps treat addictions (cannabis, nicotine…)
It is time for France to follow the example of its European neighbours so that we can enjoy all the benefits CBD has to offer.